Saturday, March 29, 2014

FDA Okays First Drug for Migraine Prevention in Adolescents

FDA Okays First Drug for Migraine Prevention in Adolescents
Medscape NeurologyHeadlines

The FDA has approved topiramate for prophylaxis of migraine in adolescents aged 12 to 17, the first such approval for this age group.
FDA Approvals

Original Article: http://www.medscape.com/viewarticle/822748?src=rss

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)